Enhanced Recovery After Surgery: Use of TAP Blocks for Postoperative Pain Control

This activity is intended for Ob/Gyn surgeons and other clinicians involved in enhanced recovery after surgery

Supported by an educational grant from:

Pacira Biosciences, Inc

Activity Information


Original Release Date: December 19, 2020
Expiration Date: January 18, 2021




From the Producers of the Pelvic Anatomy & Gynecologic Surgery Symposium

Presented by the Albert Einstein College of Medicine-Montefiore Medical Center in Joint Providership with Medscape Live


 Steven McCarus, MD, FACOG

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and Medscape Live, Inc. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 


  • Recognize the science and evidence supporting best practices in Enhanced Recovery to optimize patient outcomes. 
  • Develop a functional knowledge of core ERAS elements, understanding how several targets vary from traditional practices. 
  • Summarize the challenges facing the adoption of ERAS programs in gynecologic surgery. 

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the posttest. 

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.  

The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine-Montefiore Medical Center requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present. 
The Albert Einstein College of Medicine-Montefiore Medical Center also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.




Steven McCarus, MD

Has indicated that he has received consulting fees from Pacira Biosciences, Inc. for consultant services.


Peer Reviewer


Victor B. Hatcher, PhD

Has nothing to disclose relevant to this activity.


Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to  [email protected]

DISCLAIMERS (if applicable): 

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material. 

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine-Montefiore Medical Center, Medscape Live, Inc. or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.